Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma to announce first quarter results on August 01, 2024

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Watch Manisha Koirala’ story behind her second chance at life & why she is dedicating her #SecondBirthDate to her doctors on this #NationalDoctorsDay!

This #NationalDoctorsDay, @thesushmitasen joins Sun Pharma in dedicating her #SecondBirthDate to the Doctors who gave her a second chance at life.

If you have a similar story, visit to express gratitude to your doctor.

Engaging panel at the 9th #GPQS2024 on 'Enhancing Current Cybersecurity: Securing the Digital Future' featuring Phani Mitra B (@drreddys), Sreeji Gopinathan (@LupinGlobal), Dheeraj Sinha (@SunPharma_Live), & Sanjay Moralwar (@ZydusUniverse).

Proud moment for Sun! We've got not one but two feathers in our cap with @GPTW_India recognizing us as one of India's 50 Best Companies to Work For & Best Employers Among Nation-Builders 2024.
#bestemployersamoungnationbuilders #Indiasbestcompaniestoworkfor #GPTWCertified

We are pleased to announce the successful completion of the merger of Taro with Sun Pharma.

Read more here:

The results from a Phase I study evaluating the safety, tolerability, pharmacokinetics & pharmacodynamics of our GL0034 (Utreglutide) in obese adults, were presented at the 84th Scientific Sessions of the American Diabetes Association (ADA).

Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India.

Read more here:

Happy International Yoga Day!

Whether you're at your work desk or at home, take a break, breathe deeply, and feel the difference.


Load More

Find out more


Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.


Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.


We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.


Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue